SHP2-Targeting Small Molecules For Use As Anti-Cancer Agents
AssigneeWest Virginia University Board of Governors on behalf of West Virginia University
InventorYehenew Agazie
Life of this patent
Estimating the term…
Abstract
The present invention provides a compound of the formula: wherein R1 is a hydrogen or a COOH, R2 is a hydrogen or a COOH, R3 is a hydrogen or a COOH, R4 is one selected from the group consisting of H, COOH, and CH2COOH, and R5 is one selected from the group consisting of H, COOH, and CH2COOH. The present invention provides a compound having the formula: wherein R is COOH or CH2COOH. Pharmaceutical compositions comprising one of these compounds and at least one of an acceptable pharmaceutical carrier, are provided. Methods of treating a patient having cancer are provided.
Claims19
A compound of the formula:
- wherein R1 is a hydrogen or a COOH, R2 is a hydrogen or a COOH, R3 is a hydrogen or a COOH, R4 is selected from one of the group consisting of H, COOH, and CH2COOH, and R5 is selected from one of the group consisting of H, COOH, and CH2COOH.
A pharmaceutical composition comprising a compound having the formula:
- wherein R1 is a hydrogen or a COOH, R2 is a hydrogen or a COOH, R3 is a hydrogen or a COOH, R4 is one selected from the group consisting of H, COOH, and CH2COOH, and R5 is one selected from the group consisting of H, COOH, and CH2COOH, and
- at least one acceptable pharmaceutical carrier.
A method of treating a patient having cancer comprising administering a therapeutically effective amount of a compound of the formula:
- wherein R1 is a hydrogen or a COOH, R2is a hydrogen or a COOH, R3 is a hydrogen or a COOH, R4 is selected from one of the group consisting of H, COOH, and CH2COOH, and R5 is selected from one of the group consisting of H, COOH, and CH2COOH, for treating said patient.
A method of treating a patient having cancer comprising administering a therapeutically effective amount of a pharmaceutical composition comprising a compound having the formula:
- wherein R1 is a hydrogen or a COOH, R2 is a hydrogen or a COOH, R3 is a hydrogen or a COOH, R4 is one selected from the group consisting of H, COOH, and CH2COOH, and R5 is one selected from the group consisting of H, COOH, and CH2COOH, and
- an acceptable pharmaceutical carrier, for treating said patient.
A compound that is a derivative of CNBDA that is a phosphotyrosyl phosphatase 2 inhibitor.
A compound of the formula 4′-(carboxymethyl)-4-(nonyloxy)-[1,1′-biphenyl]-3-carboxylic acid (BPDA2).
A compound having the formula:
- wherein R is COOH or CH2COOH.
A pharmaceutical composition comprising a compound having the formula:
- wherein R is COOH or CH2COOH, and
- at least one pharmaceutically acceptable carrier.
A method of treating a patient having cancer comprising administering a therapeutically effective amount of a compound of the formula:
- wherein R is COOH or CH2COOH.
A method of treating a patient having cancer comprising administering a therapeutically effective amount of a pharmaceutical composition comprising a compound having the formula:
- wherein R is COOH or CH2COOH, and
- at least one pharmaceutically acceptable carrier, for treating said patient.
Dependencies are inferred from the claim text.